Dr. Domenico Sabia

Address: Carrer de Vilana, 12, 08022 Barcelona, Barcelona, Catalunya, Spain

Gender: Male

Type of Professional: Oncological Surgeon

Associated Healthcare Provider: QS Teknon Medical Center

Languages Spoken: English, Italian, Spanish

Contact

About the Doctor / Professional

Dr. Domenico Sabia is a renowned specialist in surgical oncology, and an expert in the treatment of peritoneal carcinomatosis. He completed his surgical training in 2008 in Italy and joined the Peritoneal Oncology Surgery Unit (UCOP) in Barcelona at the end of 2008, after training in cytoreductive surgery at the Reina Sofia University Hospital in Córdoba, at the National Cancer Institute in Milan and later at the Washington Cancer Institute with Dr. Paul Sugarbaker.

His areas of interest also include open and minimally invasive colorectal cancer surgery, laparoscopic surgery and PIPAC (Pressurized IntraPeritoneal Aerosol Chemotherapy).

Professional Experience
Research

2021 – Present: Director, Peritoneal Cancer Institute, Teknon Medical Centre, Quironsalud Hospitals Group;
2021 – Present: Senior Attending Surgeon, Peritoneal Surface Malignancies Unit, CSI, Hospital Sant Joan Despi Moisés Broggi, Barcelona
2010 – 2021: Attending Surgeon, Peritoneal Surface Malignancies Unit, CSI, Hospital Sant Joan Despi Moisés Broggi, Barcelona
2009 – 2014: Attending Surgeon in Peritoneal Surface Malignancies Surgery, Hospital de la Santa Creu i Sant Pau;
Educational stay, Center for Gastrointestinal Malignancies. Program in Peritoneal Surface Oncology, MedStar Georgetown University Hospital, Washington D.C., U.S.A
2002 – 2008: General Surgery Residency - Department of General and Transplant Surgery, Hospital Universitario Reina Sofía; Department of General and Emergency Surgery, Second University of Naples

Pedro Barrios Sanchez; Isabel Ramos Bernado; Oriol Crusellas Maña; Domenico Sabia; Sergio Mompart; Montserrat Martin Baranera. 2021. Colorectal anastomosis during cytoreductive radical surgery in patients with peritoneal surface malignancies. Validation of a new technique (without stoma) to prevent anastomosis leakage
in more than 1000 procedures.Clinical Translational Oncology.
Jordi Castellví Valls; Javier Perez Calvo; Ana Canteno Alvarez; et al; Domenico Sabia. 2018. Mechanical Reinforced Terminolateral Ileo-Transverse Anastomosis: An Option After Right Hemicolectomy - A 452 Patients Study.Surgical technology international. 33.
Domenico Sabia; Paul H. Sugarbaker. 2015. THEORETICAL CONSIDERATIONS FOR AN OPTIMAL CYTOREDUCTIVE SURGERY PLUS HYPERTERMIC PERIOPERATIVE CHEMOTHERAPY.Journal of Gastrointestinal & Digestive System. 5-6, pp.1-7. ISSN 2161-069X.
Domenico Sabia; Roman Villegas Portero. 2006. INTRAOPERATIVE RADIOTHERAPY IN ADVANCED COLORECTAL CANCER.Agencia de Evaluación de Tecnologías Sanitarias de Andalucía. ISBN 978-84-935951-2-8.
Congresses: Marina Bosch Ramírez; Domenico Sabia; Jaume Tur Martínez; Lana Bijelic. Abordaje quirúrgico de las metástasis peritoneales en zona 2 perihepática. XXIV Reunión Nacional
de Cirugía. Asociación Española de Cirujanos. 2023.
Elio Fabio-Sánchez; Domenico Sabia; Jaume Tur-Martínez; Marina Bosch-Ramírez; Ana Tejedor; Lana Bijelic. Vater: a reference centre experience Tur-Martínez J, Sorribas
M, Secanella L, Peláez N, Gornals J, Serrano T, Busquets J, Fabregat J Cir Esp (Engl Ed). 2023 Jul;101(7):490-499 Infected pancreatic necrosis: outcomes and clinical
predictors of mortality. A post hoc analysis of the MANCTRA-1 international study Mauro Podda, Gianluca Pellino, Salomone Di Saverio, Federico Coccolini, Daniela Pacella, Stefano Piero Bernardo Cioffi, Francesco Virdis, Andrea Balla, Benedetto Ielpo, Francesco Pata, Gaetano Poillucci, Monica Ortenzi, Dimitrios Damaskos, Belinda De Simone, Massimo Sartelli, Ari Leppaniemi, Kumar Jayant, Fausto Catena, Antonio Giuliani, Marcello Di Martino, Adolfo Pisanu; MANCTRA-1 Collaborative Group Updates Surg 2023
Apr;75(3):493-522 Usefulness of intraoperative bile culture in patients with acute calculous cholecystitis with previous biliary events: does the postoperative management change? Melissa Arias-Avilés, Jaume Tur-Martínez, Judith Camps-Lasa, Èric Herrero-Fonollosa, María Isabel García-Domingo, Esteban Cugat-Andorrà Eur J Clin Microbiol Infect
Dis 2023 Nov; doi: 10.1007/s10096-023-04713-7. • Presentaciones en Congresos Internacionales (Oral) PERITONEAL RECURRENCE FOLLOWING CYTOREDUCTIVE SURGERY COMBINED WITH OXALIPLATIN VS. MITOMYCIN C- BASED HIPEC FOR COLORECTAL PERITONEAL METASTASES. The 13th International Congress on Peritoneal Surface Malignancies. PSOGI. 2023.
Centralization of care leads to optimal selection and outcomes for patients with peritoneal metastases of colorectal cancer- the Catalonian regional program experience.. ESMO 22nd World Congress on Gastrointestinal Cancer. 2020.
Cytoreductive surgery with gastrectomy and HIPEC for gastric cancer with limited peritoneal metastases treated with neodjuvant systemic therapy is feasible and safe. ESMO 22nd World Congress on Gastrointestinal Cancer. 2020.
ANASTOMOSIS ILEOTRANSVERSA TERMINOLATERAL MECÁNICA REFORZADA: UNA OPCIÓN TRAS LA HEMICOLECTOMÍA DERECHA. ESTUDIO UNICÉNTRICO PROSPECTIVO OBSERVACIONAL, DESCRIPTIVO Y COMPARATIVO DE UNA SERIE DE 452 PACIENTES.. XXIII Reunión Nacional de la Fundación Asociación Española de Coloproctología. 2019. España.
1000 CRS + HIPEC procedures. Efficiency and safety results. 11th International Workshop on Peritoneal Surface Malignancies (PSOGI). 2018. Francia.
Circonferential parietal and mesenteric complete peritonectomy with CO2 pneumatization. 11th International Workshop on Peritoneal Surface Malignancies (PSOGI).. 2018. Francia.
Peritoneal metastasis (PM) from colonic origin. 423 patients treated by CRS+ HIPEC.. 11th International Workshop on Peritoneal Surface Malignancies (PSOGI).. 2018. Francia.
Urinary reconstructions after CRS + HIPEC. Ureter reconstructions.. 11th International Workshop on Peritoneal Surface Malignancies (PSOGI).. 2018. Francia.
Iterative CRS + HIPEC procedures (iHIPEC). Experience and results of the Peritoneal Catalonia Carcinomatosis Program (Spain).. 11th International Workshop on Peritoneal Surface Malignancies (PSOGI). 2018. Francia.
Recurrent ovarian cancer treated with Radical Cytorreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): 122 consecutive pacients. Catalonian Peritoneal Carcinomatosis Program (Spain).. 11th International Workshop on Peritoneal Surface Malignancies (PSOGI).. 2018. Francia.
The Right Iliac Fossa pain Treatment Audit (RIFT) group on behalf of the West Midlands Research Collaborative. International variation in the imaging of patients with right iliac fossa pain.. Association of Surgeons in Training. 2018.
The Right Iliac Fossa pain Treatment Audit (RIFT) group on behalf of the West Midlands Research Collaborative. Prospective, multicentre validation of appendicitis risk prediction models.. Association of Surgeons in Training. 2018.
The Right Iliac Fossa pain Treatment Audit (RIFT) group on behalf of the West Midlands Research Collaborative. The 2012 National Appendicectomy Audit: Re-audited. Association of Surgeons in Training. 2018.
Cytorreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in recurrent ovarian cancer: 101 consecutives patients. Catalonian Peritoneal Carcinomatosis Program (Spain). 10th International Congress on Peritoneal Surface Malignancies. 2016. Estados Unidos de América.
Organization and Structure of a National Peritoneal Surface Oncology Program: 10-year experience at the Catalonian Peritoneal Carcinomatosis Program. 10th International Congress on Peritoneal Surface Malignancies. 2016. Estados Unidos de América.
Peritoneal metastasis (PM) from gastric origin. 31 consecutive patients treated withr Radical Surgery plus Hyperthermic Intraperitoneal Chemotherapy (CRS + HIPEC). Results from the Catalonian Peritoneal Carcinomatosis Program (Spain).. 10th International Congress on Peritoneal Surface Malignancies. 2016. Estados Unidos de América.
Peritoneal metastasis from colonic origin. 289 patients treated by CRS+ HIPEC. Lessons learned in ten years experience period. Catalonian Peritoneal Carcinomatosis Program (Spain).. 10th International Congress on Peritoneal Surface Malignancies. 2016. Estados Unidos de América.
Peritoneal metastasis from unusual cancer origins. Catalonian Peritoneal Carcinomatosis Program (Spain) experience. 10th International Congress on Peritoneal Surface Malignancies. 2016. Estados Unidos de América.
Indicaciones y resultados actuales de la CRS (+ HIPEC) en la carcinomatosis gastrica.. Curso Audiovisual sobre el tratamiento radical de la carcinomatosis peritoneal. 2016. España.
INDICACIONES Y RESULTADOS DE SEGUNDOS TRATAMIENTOS DE CIRUGÍA RADICAL SEGUIDA DE QUIMIOHIPERTERMIA PERITONEAL (CR+HIPEC) EN LA CARCINOMATOSIS PERITONEAL POR RECIDIVA PERITONEAL: iCR+HIPEC. PROGRAMA DE CARCINOMATOSIS PERITONEAL DE CATALUÑA.. 30º Congreso Nacional de Cirugía. 2014. España.
TRATAMIENTO COMBINADO RADICAL DEL PSEUDOMIXOMA PERITONEAL (PP): CIRUGÍA RADICAL (CR) MÁS QUIMIOHIPERTERMIA PERITONEAL (HIPEC). RESULTADOS DEL PROGRAMA DE CARCINOMATOSIS PERITONEAL DE CATALUÑA: 99 PACIENTES CONSECUTIVOS, 119 TRATAMIENTOS. 30º Congreso Nacional de Cirugía. 2014. España.
TRATAMIENTO RADICAL DE LA CARCINOMATOSIS PERITONEAL (CP) DE COLON CON AFECTACIÓN EXTENSA MULTIVISCERAL: CIRUGÍA RADICAL (CR) MÁS QUIMIOHIPERTERMIA PERITONEAL (HIPEC). PROGRAMA DE CARCINOMATOSIS PERITONEAL DE CATALUÑA.. 30º Congreso Nacional de Cirugía. 2014. España.
Basic technical details for surgical nursing, on abdomino-thoracic radical surgery and peritoneal-thoracic chemohyperthermia (HIPEC / HITHOC), in the mucinous tumors. Hospital de Sant Joan Despí. Moises Broggi. Barcelona. Catalonian Peritoneal Carcinomatosis Program.(Spain).. 9th International Congress on peritoneal surface malignancies. 2014.
Role of nursing in perioperative phases of CRS + HIPEC. Carcinomatosis Peritoneal Programme of Catalonia (Spain).. 9th International Congress on peritoneal surface malignancies. 2014.
Selection of patients with colorectal peritoneal carcinomatosis (PC) for radical surgery (CRS) and peritoneal chemohyperthermia (HIPEC). Protocol of inclusion and results of the Peritoneal Carcinomatosis Programme of Catalonia (Spain): 200 consecutive patients. 9th International Congress on peritoneal surface malignancies. 2014.
Surgical nursing role during multidisciplinary treatment of peritoneal carcinomatosis (PC): radical cytoreductive surgery followed by intraperitoneal chemohyperthermia (CRS + HIPEC).. 9th International Congress on peritoneal surface malignancies. 2014.
Selection of patients with colorectal peritoneal carcinomatosis (PC) for radical surgery (CRS) and peritoneal chemohyperthermia (HIPEC). Protocol of inclusion and results of the Peritoneal Carcinomatosis Programme of Catalonia (Spain): 200 consecutive patients.. European Society of Coloproctology. 9th Scientific & Meeting. 2014.
La Cirugía Radical (CR) más QuimioHipertermia Peritoneal (HIPEC) en la Carcinomatosis Peritoneal (CP) es un tratamiento seguro con tasas bajas de complicaciones y mortalidad cercana al 0%. Programa de Carcinomatosis Peritoneal de Cataluña. 409 procedimientos consecutivos.. V Congreso Nacional SEOQ. Sociedad Española de Oncología Quirúrgica. V Reunión GECOP. Grupo Español de Cirugía Oncológica peritoneal. 2013. España.
Carcinomatosis Peritoneal de origen colorrectal con afectación extensa multivisceral. Cirugía Radical (CR) más Quimiohipertermia Peritoneal (HIPEC). Principios técnicos de ambas fases terapéuticas. XVII Reunión Nacional de la Fundación de la Asociación Española de Coloproctología. 2013. España.
Spanish Registry of Peritoneal Carcinomatosis.. 29º CONGRESO NACIONAL DE CIRUGÍA. 2012. España.
Carcinomatosis Peritoneal Colorrectal de volumen alto. Cirugía Radical (CR) utilizando los seis procedimientos de peritonectomía descritos más Quimiohipertermia Peritoneal (HIPEC). Principios técnicos de ambas fases terapéuticas. 29º CONGRESO NACIONAL DE CIRUGÍA. 2012. España.
Morbi-mortalidad perioperatoria del tratamiento radical de la carcinomatosis peritoneal (CP): Cirugía Radical (CR) más QuimioHipertermia Peritoneal (HIPEC) no es una objeción justificada a esta propuesta terapéutica. Programa de Carcinomatosis Peritoneal de Cataluña. 331 procedimientos consecutivos: mortalidad 0%. 29º CONGRESO NACIONAL DE CIRUGÍA. 2012. España.
Pseudomixoma Peritoneal (PP) y recidiva pleuro-pulmonar mucinosa. Cirugía radical abdomino-peritoneal y torácica (CR) seguida de Qimiohipertermia Peritoneal (HIPEC) e Intratorácica (HITHOC).. 29º CONGRESO NACIONAL DE CIRUGÍA. 2012. España.
Tratamiento radical del Pseudomixoma Peritoneal (PP): Cirugía Radical (CR) más QuimioHipertermia Peritoneal (HIPEC). Resultados de un Programa Regional de Referencia. 84 pacientes consecutivos. 29º CONGRESO NACIONAL DE CIRUGÍA. 2012. España.
CARCINOMATOSIS FROM GASTRIC ORIGEN. CYTOREDUCTIVE RADICAL SURGERY (CRS) PLUS HYPERTHERMIC INTRAOPERITONEAL CHEMOTHERAPY (HIPEC). RESULTS FROM A REFERENCE REGIONAL PROGRAM.. 8th World Congress on Peritoneal Surface Malignancies. 2012. Alemania.
Cytoreductive Radical Surgery (CRS) plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the treatment of recurrent ovarian carcinoma. Results from a reference specialized Center. 49 consecutive patients. 8th World Congress on Peritoneal Surface Malignancies. 2012. Alemania.
High tumor volume in Colorectal Peritoneal Carcinomatosis . Cytoreductive Radical Surgery (CRS) using the six described peritonectomy procedures adding Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Technical principles of both therapeutic phases.. 8th World Congress on Peritoneal Surface Malignancies. 2012. Alemania.
Morbi-mortality of Peritoneal Carcinomatosis (PC) Cytoreductive Radical Surgery (CRS) plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is not a justified objection to this therapeutic proposal. Catalonian Peritoneal Carcinomatosis Program. 333 consecutive procedures: mortality 0%.. 8th World Congress on Peritoneal Surface Malignancies. 2012. Alemania.
Peritonei Pseudomyxoma (PMP) treatment: Cytoreductive Radical Surgery (CRS) plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Results from a reference regional program. 84 consecutive patients.. 8th World Congress on Peritoneal Surface Malignancies. 2012. Alemania.
Prevention of Occupational Risks in the Implementation of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis (PC). Catalonian Peritoneal Carcinomatosis Program.. 8th World Congress on Peritoneal Surface Malignancies. 2012. Alemania.
Radical Treatment of Carcinomatosis of Colorectal Origin: Cytoreductive Radical Surgery (CRS) plus Hyperthermic Intraperitoneal Chemoterapy (HIPEC). Results of a reference program. 125 consecutive patients.. 8th World Congress on Peritoneal Surface Malignancies. 2012. Alemania.
Recomendaciones para la toma de decisiones terapéuticas ante situaciones clínicas específicas de carcinomatosis peritoneal en paciente potencialmente tratables con la Técnica de Sugarbaker.. 28º Congreso Nacional de Cirugía. 2010. España.
Registro Español de Carcinomatosis Peritoneal: Primeros resultados.. 28º Congreso Nacional de Cirugía. 2010. España.
Seguridad clínica de la Técnica de Sugarbaker en el tratamiento de la Carcinomatosis Peritoneal. Morbi/mortalidad en 166 procedimientos consecutivos. Programa de Carcinomatosis Peritoneal de Cataluña.. 28º Congreso Nacional de Cirugía. 2010. España.
Tratamiento de la carcinomatosis colorrectal mediante la Técnica de Sugarbaker. Resultados del Programa de Carcinomatosis Peritoneal de Cataluña.. 28 Congreso Nacional de Cirugía. 2010. España.
Tratamiento del Pseudomixoma Peritoneal mediante la Técnica de Sugarbaker. Resultados del Programa de Carcinomatosis Peritoneal de Cataluña. 28º Congreso Nacional de Cirugía. 2010. España.
Tratamiento de la carcinomatosis colorrectal mediante CRS+HIPEC (Técnica de Sugarbaker). Resultados clínicos del Programa de Carcinomatosis Peritoneal de Cataluña.. XX JORNADES DE CIRURGIA ALS HOSPITALS DE CATALUNYA. XIII JORNADES D’INFERMERIA DE CIRURGIA. 2010. España.
Tratamiento del pseudomixoma peritoneal con citorreducción radical y quimiohipertermia. Resultados del Programa de Carcinomatosis Peritoneal de Cataluña.. XX JORNADES DE CIRURGIA ALS HOSPITALS DE CATALUNYA. XIII JORNADES D’INFERMERIA DE CIRURGIA. 2010. España.
Técnica de Sugarbaker en el tratamiento de la Carcinomatosis Peritoneal. Experiencia sobre 180 pacientes consecutivos con mortalidad del 0%. Programa de Carcinomatosis Peritoneal de Cataluña.. XX JORNADES DE CIRURGIA ALS HOSPITALS DE CATALUNYA. XIII JORNADES D’INFERMERIA DE CIRURGIA. 2010. España.
Pleuro-Pulmonar mucinosis disease in treated patients of Peritoneal Pseudomixoma. Radical surgery + Intrathoracic Chemotherapy.. 7th International Workshop on Peritoneal Surface Malignancy. 2010. Suecia.
Pleuro-pulmonary involvement secondary to mucinous tumor in patients with Peritoneal Pseudomixoma.. 7th International Workshop on Peritoneal Surface Malignancy. 2010. Suecia.
Spanish Registry of Peritoneal Carcinomatosis. Early Sept 2010 results and forecasts.. 7th International Workshop on Peritoneal Surface Malignancy. 2010. Suecia.
Sugarbaker technique for the treatment of Peritoneal Surface Malignancy (PSM). Catalonian´s Peritoneal Carcinomatosis Group experience: 166 consecutive procedures with a 0% mortality rate.. 7th International Workshop on Peritoneal Surface Malignancy. 2010. Suecia.
Treatment of Peritoneal Carcinomatosis from colorectal cancer (CRS + HIPEC). Catalonian Peritoneal Carcinomatosis Programme Clincal results.. 7th International Workshop on Peritoneal Surface Malignancy. 2010. Suecia.
Treatment of Pseudomixoma Peritonei (PMP) with Cytoreductive Surgery (CRS) + Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - Sugarbaker technique.. 7th International Workshop on Peritoneal Surface Malignancy. 2010. Suecia.
Afectación pleuro-pulmonar por tumor mucinosos en pacientes con Pseudomixoma Peritoneal.. III Reunión Nacional de la Carcinomatosis Peritoneal. 2008. España.
Evaluación de riesgos durante la administración de la quimiohipertermia peritoneal (HIPEC).. III Reunión Nacional de la Carcinomatosis Peritoneal. 2008. España.
Revisión sistemática del tratmiento multidisciplinar: cirugía radical + quimioterapia intraperitoneal +/- hipertermia (Técnica Sugarbaker) en las enfermedades malignas del peritoneo.. III Reunión Nacional de la Carcinopmatosis Peritoneal. 2008. España.
Tratamiento de la carcinomatosis colorrectal mediante cirugía radical y quimoterapia hipertérmica peritoneal.. III Reunión Nacional de la Carcinomatosis Peritoneal. 2008.
Tratamiento del Pseudomixoma Peritoneal mediante cirugía radical y quimiohipertermia peritoneal (Técnica de Sugarbaker).. III Reunión Nacional de la Carcinomatosis Peritoneal. 2008. España.
Técnica de Sugarbaker en la Carcinomatosis peritoneal. Implementación de una Unidad Terapéutica especializada. Resultados clínicos.. III Reunión Nacional de la Carcinomatosis Peritoneal. 2008. España.
Peritoneal metastasis (PM) from gastric origin. 45 consecutive patients treated with Radical Cytorreduction and Hyperthermic Intraperitoneal Chemotherapy (CRS + HIPEC). Results from the Catalonian Peritoneal Carcinomatosis Program (Spain).. 11th International Workshop on Peritoneal Surface Malignancies (PSOGI).. 2018. Francia.
The Right Iliac Fossa pain Treatment Audit (RIFT) group on behalf of the West Midlands Research Collaborative. National audit of the management of right iliac fossa pain in children.. Association of Surgeons in Training. 2018.
Projects and Contracts: Pseudomyxoma peritonei building a European multicentric cohort to accelerate new therapeutic perspectives Accelerator European multicentric study Marcello Deraco. (Fondazione IRCCS - Istituto Nazionale dei Tumori). Desde 2019.
Pan-European Snapshot Audit. Closure of Intestinal Stoma Desde 01/2016.
Pan-European snapshot audit. Right Hemicolectomy / Ileo-caecal resection. Desde 01/2015.
Ensayo Clínico multicéntrico, randomizado, para evaluar la eficacia y seguridad de la quimioterapia intraperitoneal hipertérmica (HIPEC) con Mitomicina C asociada a cirugía en el tratamiento del carcinoma colorectal localmente avanzado Alvaro Arjona. Desde 2015
Stays in public or private R&D&I centers:
Center for Gastrointestinal Malignancies and Program in Peritoneal Surface Oncology. MedStar Washington Hospital Center - Washington Cancer Institute. Estados Unidos de América. Washington DC. 11/2014-01/2015. Fellow

Specialties and Procedures
Healthcare Providers

Cancer/Oncology Learn More about Cancer/Oncology

Appendix Cancer
Cancer/Oncology Consultation
Colorectal Cancer
Cytoreductive Surgery
Cytoreductive Surgery with HIPEC
Malignant Mesothelioma Treatment
Ovarian Cancer with Peritoneal Metastasis
Peritoneal Carcinomatosis
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)
Pseudomyxoma Peritonei (PMP)
Stomach Cancer Treatment
Surgical Oncology

Colorectal Medicine Learn More about Colorectal Medicine

Colorectal Cancer

QS Teknon Medical Center

Search by Specialty